Yamasa

Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV
Yahoo
Tue, 07/24/12 - 09:19 am
MK-1439
Merck
HIV
Yamasa
Chimerix
CMX157
EFdA